OncoSec Medical proclaims preliminary clinical observations of OMS-1140 Clinical Trial of ImmunoPulse in TNBC patients Read more
Ligand Pharmaceuticals initiates a program to develop contrast agents for Diagnostic Imaging Read more
Pandion Therapeutics sought $58 million Series A funding to advance drug programs for autoimmune and inflammatory diseases Read more
Kite and Pfizer extend Clinical Trial collaboration to assess Yescarta in large B-cell lymphoma Read more